Featuring: Vladimir Badovinac, PhD; John Harty, PhD; Mohammad Heidarian, MSc; Shravan Kannan, MS; Sergei Syrbu, MD, PhD

The Bosch Lab, led by Dustin Bosch, MD, PhD, is studying how the gut microbiome is related to CAC development. IBD patients have perturbed microbiomes (dysbiosis), and specific bacteria (pathobionts) may promote carcinogenesis in the inflamed intestine.

Featuring: Jonathan Davick, MD; Di Hu, PhD; Hui Li, PhD; Hong Lin, BS; Jia Luo, PhD; Ashutosh Mangalam, PhD; Osorio Lopes Abath Neto, MD, PhD; Mrutyunjaya Parida, PhD; Shaelish Shahi, PhD; Wen Wen, PhD; Zuohui Zhang, MD, PhD

Dr. Shailesh Shahi has been awarded a three-year, $999,265 grant from the Department of Defense Multiple Sclerosis Research Program (DoD-MSRP) for his project titled “Impact of Obesity-Driven Gut Microbiota Alterations on Multiple Sclerosis.”

Researchers in Ashutosh Mangalam, PhD’s research laboratory, in collaboration with University of Iowa College of Nursing, University of Iowa College of Public Health, and University of Iowa Department of Neurology, have identified a microbial ratio in the gut microbiome associated with multiple sclerosis and disease severity.

Featuring: Dawn Quelle, PhD

Dr. Mariah Hassert, a Postdoctoral Scholar in the laboratory of Dr. John Harty, received a K99/00 Pathway to Independence award from the National Institutes of Allergy and Infectious Diseases for her proposal “Hemozoin and liver stage malaria vaccine efficacy”.

Featuring: Andrew Bellizzi, MD; Tanner J. Simonson, MD; and Mary Stone, MD, FAAD

Congratulations to Prerna Rastogi, MD, PhD, who has been appointed as Medical Director of the University of Iowa Diagnostic Laboratories (UIDL).

Harty and Badovinac Research Labs investigate how physiological microbial exposures normalize memory T cell presence in the brain and influence neurological disease outcomes.